Research Papers

25 of 2183 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported O…
Moreno Vanegas Y; Badar T.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immuno…
Shu CL; Liu YL.
Cancer Manag Res (Unknown)
Published: 2022
2/6 Transparent
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases.
Shiraishi Y; Shimose T; Tsuchiya-Kawano Y; Ishii H; Daga H; Ito K; Saruwatari K; Okamoto I.
Cancer Manag Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosi…
Gaitonde P; Chirikov V; Kelkar S; Liljas B.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Health-Related Quality of Life of Patients with Metastatic Pancreatic Cancer: A Systematic Literature Review.
Yoo HK; Patel N; Joo S; Amin S; Hughes R; Chawla R.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients.
Kicman A; Niczyporuk M; Kulesza M; Motyka J; Ławicki S.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug T…
Li Q; Hu C; Su S; Ma Z; Geng Y; Hu Y; Li H; Lu B.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pathological Features of Ovarian Tumors, Diagnosed at a Tertiary Care Hospital in Afghanistan: A Cross-sectional Study.
Ibrahimkhil AS; Malakzai HA; Haidary AM; Hussaini N; Abdul-Ghafar J.
Cancer Manag Res (Unknown)
Published: 2022
2/6 Transparent
Human Papillomavirus-Associated Head and Neck Cancers. Where are We Now? A Systematic Review.
Pinkiewicz M; Dorobisz K; Zatoński T.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis.
Sun SJ; Deng P; Peng CE; Ji HY; Mao LF; Peng LZ.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Foc…
Crimp C; Gangal A; Tarabadkar ES; Shinohara MM.
Cancer Manag Res (Unknown)
Published: 2022
2/6 Transparent
RNA Modifications Meet Tumors.
Yang Z; Zhang S; Xia T; Fan Y; Shan Y; Zhang K; Xiong J; Gu M; You B.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
"Micro" Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermedia…
He Q; Ji F; Fu X; Li Z; Qiu X.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expre…
Ge W; Wu N; Jalbert JJ; Quek RGW; Liu J; Rietschel P; Pouliot JF; Harnett J; Hsu ML; Feliciano JL.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and Considerations.
Wu MS; Goldberg H.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple S…
Lin PT; Hsieh ML; Su SH; Chang YH; Huang LK; Chu YC; Kan HC; Lin PH; Yu KJ; Chuang CK; Wu CT; Pang ST; Shao IH.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of the Position Error of Wearing Surgical Masks During Radiotherapy in Head and Neck Cancer Patients.
Chan SH; Huang YY; Tsai SH; Wang JC; Chen YR; Kang CL.
Cancer Manag Res (Unknown)
Published: 2022
2/6 Transparent
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Surviv…
Dal Maso L; Santoro A; Iannelli E; De Paoli P; Minoia C; Pinto M; Bertuzzi AF; Serraino D; De Angelis R; Trama A; Haupt R; Pravettoni G; Perrone M; De Lorenzo F; Tralongo P; Alliance Against Cancer (ACC) Survivorship Care and Nutritional Support Working Group.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective.
Nervo A; Retta F; Ragni A; Piovesan A; Gallo M; Arvat E.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with…
Kubota Y; Aoki Y; Kawazoe A; Shitara K.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical Significance of <i>Fusobacterium nucleatum</i> and Microsatellite Instability in Evaluating Colorectal Cancer …
Xie Y; Jiao X; Zeng M; Fan Z; Li X; Yuan Y; Zhang Q; Xia Y.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patient…
Li D; Darden C; Osman N; Sayeed S; Jackson L; Garbinsky D; Chauhan A.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Gender Differences in Quality of Life of Metastatic Lung Cancer Patients.
Koch M; Rasch F; Rothammer T; Müller K; Mohr A; Koller M; Schulz C.
Cancer Manag Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
The Failure Patterns of Nasopharygeal Carcinoma After Intensity-Modulated Radiotherapy and Implications for Surveillanc…
Tian Y; Huang WZ; Zeng L; Bai L; Han F; Lan Y.
Cancer Manag Res (Unknown)
Published: 2022
2/6 Transparent
The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standar…
Wang T; Lin F; Huang Y; Qian G; Yu W; Hu H; Ji T; Tang L; Yao Y.
Cancer Manag Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared